KeyVexKeyVex
Sign in
KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Kurt Schrader (House) disclosed 3 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

Amendment status is not available for House filings. A filing listed here may since have been amended.

2014-04-23 · sellAllergan — $1,001 - $15,000
2014-04-24 · sellAstraZeneca PLC — $1,001 - $15,000
2014-04-22 · buyCelgene Corp — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerJoint
partyDemocrat
stateOR
officeSchrader, Kurt (Representative)
ptr id8214725
chamberhouse
comment—
amount max15000
amount min1001
asset typeStock
report urlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2014/8214725.pdf
bioguide idS001180
data sourceHOUSE_CLERK_PTR
member lastSchrader
member nameKurt Schrader
amount range$1,001 - $15,000
member firstKurt
state districtOR05
disclosure date2014-05-07
extraction methodvision_ocr

Each transaction (3)

idtickerasset nametransaction datetransaction typereporting lag days
house-8214725-ocr-3AGNAllergan2014-04-23sell10
house-8214725-ocr-2AZNAstraZeneca PLC2014-04-24sell9
house-8214725-ocr-1CELGCelgene Corp2014-04-22buy11

Original filing document